BenevolentAI, a British-based drug developer, is facing a boardroom coup led by its founder after seeing its shares slump since it floated little more than two years ago.
Baroness Shields has stepped down as chief executive of BenevolentAI as the drugs developer pushes ahead with a widespread restructuring.Shields, 61, a former t
The biotechnology company led by Baroness Shields, the former technology adviser to David Cameron, is to cut about half of its workforce as it redraws it